Cargando…
Gut Microbiome Composition Is Associated with COVID-19 Disease Severity
Autores principales: | Patel, Pooja, Roper, Jatin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the AGA Institute
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116123/ https://www.ncbi.nlm.nih.gov/pubmed/33991578 http://dx.doi.org/10.1053/j.gastro.2021.05.006 |
Ejemplares similares
-
Inflammatory Bowel Diseases and COVID-19: The Invisible Enemy
por: D’Amico, Ferdinando, et al.
Publicado: (2020) -
COVID-19 mRNA Vaccine Short-Term Safety in Patients With Inflammatory Bowel Disease
por: Spiera, Emily, et al.
Publicado: (2022) -
Steering a Course through the COVID-19 Pandemic: Should the SECURE-IBD Registry Influence Prescribing for Patients with Inflammatory Bowel Disease?
por: Gomes, Catarina Frias, et al.
Publicado: (2021) -
Is Promotion of Fecal Immunochemical Testing “FIT” to Address COVID-19 Disruptions to Colorectal Cancer Screening?
por: Trivedi, Mehul, et al.
Publicado: (2022) -
Is periodontitis associated with the severity of COVID-19?
por: Shamsoddin, Erfan
Publicado: (2021)